The funding will be used to expand the product line for remote patient monitoring and to establish a strong presence in Asia and Africa, including India, Japan and China
Analytics firm Tricog has raised $10.5 million in Series B funding round from UTEC – The University of Tokyo Edge Capital, Japan; Aflac Ventures, Japan; TeamFund, USA and Dream Incubator, Japan. Existing investors Inventus Capital and Blume Ventures also participated in this round.
The investment comes two years after Tricog’s Series A funding round, bringing the company’s total funding to $17.5 million. Since the previous round, Tricog has grown its presence in over 12 countries in South-East Asia and Africa. Tricog’s AI-powered platform has been used by over three million patients globally for wellness, screening and diagnosis of acute as well as chronic heart diseases.
Dr Charit Bhograj, CEO and Founder, Tricog said, “We have witnessed phenomenal growth from our initial investments, both in terms of footprints in new geographies as well as revenue growth. Through this round of investment, we reinforce our commitment to strengthen our AI-powered platform for faster diagnosis, expand our product line and establish a strong presence in Africa and Asia including India, China and Japan.”
Tricog has recently launched the InstaEcho platform for remote echocardiography with a focus on using AI to enable Point of Care Cardiac Ultrasound for the diagnosis of Heart Failure, Valvular Heart disease and screening for Congenital Heart Disease. Tricog is also awaiting US FDA approval for its proprietary DeepRhythm platform for real-time patient monitoring.